MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy

Numerous clinical trials of mesenchymal stromal/stem cells (MSCs) as a new treatment for coronavirus-induced disease (COVID-19) have been registered recently, most of them based on intravenous (IV) infusion. There is no approved effective therapy for COVID-19, but MSC therapies have shown first prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Moll, Guido, Drzeniek, Norman, Kamhieh-Milz, Julian, Geissler, Sven, Volk, Hans-Dieter, Reinke, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249852/
https://www.ncbi.nlm.nih.gov/pubmed/32574263
http://dx.doi.org/10.3389/fimmu.2020.01091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249852/
https://www.ncbi.nlm.nih.gov/pubmed/32574263
http://dx.doi.org/10.3389/fimmu.2020.01091

Ejemplares similares